Article | November 20, 2018

Clinical Supply Chain Success: Leveraging Technology

Source: Bioclinica

Kevin Bishop, Global Vice President & General Manager Randomization & Trial Supply Management, Bioclinica

The availability of investigational product often determines the success of a clinical trial's randomization and trial supply management (RTSM) solution. RTSM solutions are a key component of the clinical supply chain, the purpose of which is to ensure that the correct investigational product is at the right site at the right time for a subject. When the clinical supply chain fails to achieve this goal, the subjects as well as the entire study are affected.

Maintaining the right balance between having sufficient stock for all sites and subjects and avoiding overstocking and wastage of investigation product is challenged by the many complex processes across multiple organizations the characterize clinical trials today. Clinical teams work hard to avoid stock out situations, in particular, because of the significant financial and operational pain they create.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader